400 Summit Drive
16 articles with MilliporeSigma
AISF was developed through a research collaboration with Pfizer Inc.
BioReliance® Viral and Gene Therapy Assay Portfolio wins award in Analytical/Test category
Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology
New BioContinuum™ Platform provides benefits now, with a mind to continuous process of the future
Superior quality ultrapure and pure water in an ergonomic and compact design, to improve productivity, reduce waste and accelerate research
Company awarded for excellence in innovation for Parteck® MXP Excipient and modified amino acids
MilliporeSigma Offers Rhabdovirus-free Insect Platform for Viral Vaccines and Gene Therapy Development
Exclusively licensed, rhabdovirus-free platform enables more productive bioprocessing
MilliporeSigma’s Novel Chemiflex™ Raw Materials Program Solves Regulatory Compliance Challenges in Small Molecule Drug Manufacturing
Bridges the raw material qualification gap, simplifying scale-up to cGMP manufacturing of active pharmaceutical ingredients
Four graduate student chemists awarded for innovation in synthetic organic chemistry
Technologies include first-of-its-kind cation exchange (CEX) chromatography resin for flow-through removal of mAb aggregates
Synthia™ software (formerly Chematica) commercially launches at ACS 2018.
Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research
MilliporeSigma Introduces BioReliance® Droplet Digital PCR Technology for Cell and Gene Therapy Development
MilliporeSigma Introduces BioReliance® Droplet Digital PCR Technology for Cell and Gene Therapy Development.
Quartzy, the only free online laboratory supply management and ordering platform, announced today its partnership with South Elgin-based BioBlaze Community Bio Lab to provide the non-profit’s scientists with access to competitive terms on laboratory supplies and enhanced support tailored to their emergent scientific endeavors.
MilliporeSigma officially opened North America's first BioReliance® End-to-End Biodevelopment Center providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers.
Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children